Operationalization of Bispecific Antibodies in Non-Hodgkin Lymphoma (NHL)

home / precision-medicine / operationalization-of-bispecific-antibodies-in-non-hodgkin-lymphoma-nhl

Medical experts discuss bispecific antibody utilization in the management of non-Hodgkin lymphoma (NHL).

Intro and Overview of Bispecifics in Non-Hodgkin Lymphoma (NHL)

EP. 1: Intro and Overview of Bispecifics in Non-Hodgkin Lymphoma (NHL)

Jennifer Crombie, MD ;Matthew J. Matasar, MD
September 30th 2024

Panelists discuss how bispecific antibodies are transforming the treatment landscape for non-Hodgkin lymphoma by enhancing T cell engagement and targeting malignant B cells effectively.

Watch